Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma

[1]  D. Aust,et al.  Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas , 2013, Annals of surgery.

[2]  Seung‐Mo Hong,et al.  Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas. , 2013, American journal of clinical pathology.

[3]  A. Vanoli,et al.  The contribution of cell phenotype to the behavior of gastric cancer , 2013, Gastric Cancer.

[4]  Y. Bang,et al.  Concordance of ATM (Ataxia Telangiectasia Mutated) Immunohistochemistry between Biopsy or Metastatic Tumor Samples and Primary Tumors in Gastric Cancer Patients , 2013, Pathobiology.

[5]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[6]  Seung‐Mo Hong,et al.  Loss of S100A14 Expression Is Associated with the Progression of Adenocarcinomas of the Small Intestine , 2012, Pathobiology.

[7]  W. Kimura,et al.  Expression of MUC1 and MUC2 in Ampullary Cancer , 2011, International journal of surgical pathology.

[8]  M. Fukayama,et al.  Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer. , 2011, International journal of clinical and experimental pathology.

[9]  S. Çelik,et al.  Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma. , 2010, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[10]  Y. Kawabata,et al.  Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis , 2010, Diagnostic pathology.

[11]  Jason Y. Park,et al.  Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases. , 2010, Human pathology.

[12]  D. Lobo,et al.  Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer , 2010, The British journal of surgery.

[13]  W. Kimura,et al.  Intraductal Papillary-Mucinous Neoplasms of the Gastric and Intestinal Types May Have Less Malignant Potential Than the Pancreatobiliary Type , 2010, Pancreas.

[14]  S. Kopetz,et al.  Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine , 2009, British Journal of Cancer.

[15]  K. Kumamoto,et al.  CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. , 2009, Oncology reports.

[16]  J. Ge,et al.  A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  Hua-Chuan Zheng,et al.  The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. , 2008, Anticancer research.

[18]  D. Shen,et al.  Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  P. Hui,et al.  Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. , 2007, American journal of clinical pathology.

[20]  K. Tsuneyama,et al.  MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays , 2006, Journal of Cancer Research and Clinical Oncology.

[21]  J. Heo,et al.  CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype , 2006, Scandinavian journal of gastroenterology.

[22]  Ji‐you Li,et al.  Expression of Cdx2 and Hepatocyte Antigen in Gastric Carcinoma: Correlation with Histologic Type and Implications for Prognosis , 2005, Clinical Cancer Research.

[23]  A. Hölscher,et al.  Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. , 2005, World journal of gastroenterology.

[24]  P. Argani,et al.  Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Y. Yen,et al.  Immunohistochemical Staining in the Diagnosis of Pancreatobiliary and Ampulla of Vater Adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2 , 2005, The American journal of surgical pathology.

[26]  M. Loda,et al.  The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas , 2004, Modern Pathology.

[27]  A. Soran,et al.  Prognostic Significance of Mucin Expression in Gastric Carcinoma , 2004, Digestive Diseases and Sciences.

[28]  R. Penzel,et al.  Mutational activation of the RAS‐RAF‐MAPK and the wnt pathway in small intestinal adenocarcinomas , 2004, Scandinavian journal of gastroenterology.

[29]  T. Tsukamoto,et al.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis , 2003, Journal of Cancer Research and Clinical Oncology.

[30]  C. Moskaluk,et al.  Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays , 2003, Modern Pathology.

[31]  H. Lee,et al.  Expression of Mucins and Cytokeratins in Primary Carcinomas of the Digestive System , 2003, Modern Pathology.

[32]  A. Gown,et al.  CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.

[33]  J. Rossen,et al.  The MUC family: an obituary. , 2002, Trends in biochemical sciences.

[34]  M. Koike,et al.  Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. , 2002, Cancer letters.

[35]  W. Bodmer,et al.  An insight into the genetic pathway of adenocarcinoma of the small intestine , 2002, Gut.

[36]  H. Ajisaka,et al.  Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer. , 2001, Hepato-gastroenterology.

[37]  P. Traber,et al.  Cdx1 and cdx2 expression during intestinal development. , 2000, Gastroenterology.

[38]  A. Neugut,et al.  Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Dagorn,et al.  Expression of the Cdx1 and Cdx2 Homeotic Genes Leads to Reduced Malignancy in Colon Cancer-derived Cells* , 1998, The Journal of Biological Chemistry.

[41]  T. Muto,et al.  Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of Vater , 1994, Japanese journal of cancer research : Gann.

[42]  J. Burke,et al.  Carcinoma of the colon and rectum. , 1962, The New England journal of medicine.

[43]  G. Miller.  Carcinoma of the Colon and Rectum. , 1942, Canadian Medical Association journal.

[44]  G. Zamboni,et al.  Adenomas and other premalignant neoplastic lesions of the ampullary region , 2010 .

[45]  D. Park,et al.  CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance , 2010, Modern Pathology.

[46]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[47]  Barry J. Allen,et al.  MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer , 2005, Clinical & Experimental Metastasis.

[48]  A. Neugut,et al.  Frequent K-ras mutations in small bowel adenocarcinomas , 2005, Digestive Diseases and Sciences.

[49]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[50]  I Duluc,et al.  The Cdx-1 and Cdx-2 homeobox genes in the intestine. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[51]  D. Nolan,et al.  Carcinoma of the small intestine. , 1985, Clinical radiology.

[52]  F. D. Ackman.  CARCINOMA OF THE SMALL INTESTINE. , 2022, Canadian Medical Association journal.